Autologous Stem Cell Transplantation (Autologous Bone Marrow Transplantation) for Pediatric Ewing Sarcoma at Sheba Hospital - a JCI accredited and Top-10 Hospitals 2026 by Newsweek
$79,000
/ Hana Golan
24
years of experience
Hana Golan
- Specialization: Hematologist
- 24 years of experience
- Speaks:English, Hebrew
- Workplace: Israel, Ramat Gan, Sheba Medical Center
- Serves as Director of Pediatric Hemato-Oncology & BMT and Principal Investigator of the High-Risk Neuroblastoma ESIOP protocol.
Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.
- National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
- Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
- Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
- Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.
Explore package deals with Dr. Hana Golan
Complex treatment of Ewing's sarcoma
per package
The package includes a standard range of medical services offered by the clinic and additional benefits like accommodation, transfer, etc.
Doctor's services
- Chemotherapy
- Lymphoma chemotherapy
- Biological therapy
- Plasmapheresis
- Allogenic bone marrow transplantation from an unrelated donor
- Plasma Exchange
- Therapeutic Apheresis
- Bone marrow transplantation
- CAR T-cell therapy
- Leukemia chemotherapy
- Haploidentical Stem Cell Transplantation
- Allogenic bone marrow transplantation from a related donor
- DFPP Plasmapheresis
- Selective Apheresis
- Immunotherapy
- Immunotherapy with Keytruda (Pembolizumab)
- Lymph node dissection
- Lymphadenectomy
- Conservative treatment
- Symptomatic treatment
- Inpatient treatment per day
- Drug treatment
- Course of treatment with own stem cells
- Mesenchymal stem cell therapy
- Umbilical cord stem cell therapy
- Individual Counselling
- Course of treatment with donor stem cells
- Embryonic stem cell therapy
- Ultrasound
- CT (computer tomography)
- Biopsy
- Tumor Marker Blood Test
- Immunohistochemistry
- MRI of one area
- PET/CT
- Mammography
- Whole-body MRI
- Colonoscopy
- HLA-typing
- Bone marrow biopsy
- Online Consultation with Oncologist
- Brain MRI
View more
How are we doing?
1 of 3
Information about this doctor is full and clear
1
2
3
4
5
Strongly disagree
Strongly agree
Qualifications
Dr. Hana Golan is the Director of the Pediatric Hemato-Oncology and BMT Division at Sheba Medical Center. She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. Dr. Golan treats complex childhood cancers at a facility ranked among the top 10 hospitals worldwide. She also leads one of the most advanced pediatric oncology programs in the region.
Specialization and Clinical Focus
Dr. Golan treats high-risk pediatric cases using oncology and stem cell transplantation protocols. Her work involves childhood hematologic malignancies and aggressive solid tumors. This clinical focus includes treats several conditions, including:
- Neuroblastoma and high-risk solid tumors
- Leukemia, including acute lymphoblastic leukemia
- Lymphomas, such as Hodgkin's and Non-Hodgkin's types
- Aplastic anemia and other bone marrow failure syndromes
- Sickle cell anemia and inherited blood disorders
- Immune deficiencies and metabolic disorders
The doctor performs procedures such as CAR T-cell therapy and allogenic bone marrow transplants. She uses haploidentical stem cell transplantation and personalized chemotherapy to improve outcomes. Dr. Golan also implements computerized safety protocols for chemotherapy administration. Additionally, she developed systems to improve clinical workflow and patient safety.
Research and Clinical Trials
Dr. Golan coordinates international multicenter oncology protocols to advance pediatric care. She serves as an investigator in international Phase I and II clinical trials. Her research investigates cancer stem cells and novel targeted therapies. The specialist also explores emerging therapeutic strategies involving cannabinoid-related oncology for treatment-resistant malignancies.
Academic and Professional Roles
- Director, Pediatric Hemato-Oncology and BMT Division, Sheba Medical Center
- Senior Lecturer, Sackler Faculty of Medicine, Tel Aviv University
- National Coordinator of multicenter oncology protocols
- Coordinator of hematology training programs for medical students
- Lecturer in pediatric hematology-oncology for physicians and nurses
Education and Training
- Medical Degree (MD), Rappaport Faculty of Medicine, Technion – Israel Institute of Technology
- Residency in Pediatrics, Sheba Medical Center
- Residency in Pediatric Hematology-Oncology, Sheba Medical Center
- Research Training in Transplantation Immunology, Weizmann Institute of Science
- Advanced training in clinical research, biomedical informatics, and healthcare management
- Board Certification in Pediatrics
- Board Certification in Pediatric Hematology-Oncology
Professional Publications
Dr. Golan contributes to peer-reviewed literature regarding pediatric cancer treatments. Notable works include:
- "Primary immunodeficiency syndromes in Israel"
- "Integration of palliative care in pediatric oncology"
You may also be interested
Payment & Rewards
You don’t pay for our services
You make your payment directly at the clinic or to their official bank account.
Secure Booking
Some clinics may require a deposit as a part of their policy.
Flexible installments
Spread out your payments with installment options.
Referral program
Earn rewards for referring friends to Bookimed.